Song Wen-Chong, Qiao Xiu-Li, Gao Xiao-Zhong
Gastroenterology Division, Weihai Municipal Hospital, Weihai, 264200, People's Republic of China.
World J Surg Oncol. 2015 Nov 4;13:309. doi: 10.1186/s12957-015-0724-1.
Endoscopic submucosal dissection (ESD) has become one of the mainstays of treatment for early gastric cancer (EGC). Radical surgery is also a classical treatment method for EGC. There have been no systematic clinical studies of the curative effects and adverse events associated with ESD vs. radical surgery for EGC. This study investigated the therapeutic efficacy and safety of ESD and radical surgery for EGC.
Twenty-nine patients with EGC underwent ESD, and 59 underwent radical surgery at Weihai Municipal Hospital. The pathological characteristics, postoperative outcomes, hospital course, morbidity and mortality were retrospectively compared between the two groups.
The oncological clearance was 93.1 % (27/29) in the ESD group. Postoperative delayed haemorrhage occurred in two patients. The hospital stay ranged from 10 to 23 days, and the average stay was 14.3 ± 3.7 days. The patients were followed-up for 1 to 5 years, with a mean follow-up of 26.9 ± 8.5 months. Regular endoscopic examinations showed that the wound had healed with no cancer recurrence in all of the patients. In the radical surgery group, the oncological clearance was 100 % (59/59). The hospital stay ranged from 11 to 55 days, and the average stay was 21.7 ± 9.3 days. The patients were followed-up for 1 to 3.7 years, with a mean follow-up of 22.3 ± 9.4 months. Nine patients developed complications, including acute postoperative adhesive ileus (1/59) and symptomatic residual gastritis (3/59). These complications were improved by an additional operation, drainage, gastrointestinal decompression and comprehensive therapy.
ESD achieved similar efficacy and had many advantages compared with radical surgery for the treatment of EGC.
内镜黏膜下剥离术(ESD)已成为早期胃癌(EGC)的主要治疗手段之一。根治性手术也是EGC的经典治疗方法。目前尚无关于ESD与根治性手术治疗EGC的疗效及不良事件的系统性临床研究。本研究探讨了ESD与根治性手术治疗EGC的疗效及安全性。
29例EGC患者在威海市立医院接受了ESD治疗,59例接受了根治性手术。对两组患者的病理特征、术后结果、住院过程、发病率和死亡率进行回顾性比较。
ESD组的肿瘤切除率为93.1%(27/29)。2例患者术后发生延迟性出血。住院时间为10至23天,平均住院时间为14.3±3.7天。患者随访1至5年,平均随访26.9±8.5个月。定期内镜检查显示所有患者伤口均已愈合,无癌症复发。在根治性手术组中,肿瘤切除率为100%(59/59)。住院时间为11至55天,平均住院时间为21.7±9.3天。患者随访1至3.7年,平均随访22.3±9.4个月。9例患者出现并发症,包括急性术后粘连性肠梗阻(1/59)和症状性残余胃炎(3/59)。这些并发症通过再次手术、引流、胃肠减压及综合治疗得到改善。
ESD在治疗EGC方面与根治性手术疗效相似且具有诸多优势。